87 days ago
Very ostentatiously the bearded Poltroon, Stuart Ashman of Skinbiotherapeutics (SBTX) and his, now thankfully departed, CFO Manprick took a 20% pay cut in early 2024 backdated to January 1 of that year. They did so as targets had been missed and more shares had needed to be issued. As Call Me Dave used to, mendaciously, comment “We are all in it together.”
